Chakma Justin bought SPRY

November 12, 2025 · Form 4 insider transaction

Chakma Justin bought 30,000 shares of ARS Pharmaceuticals, Inc. at $0.84 per share, a transaction worth $25.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.